Silver Book Fact

A meta-analysis of antidepressants found that 1 in 3 patients with persistent neuropathic pain will get at least moderate pain relief. Another meta-analysis of duloxetine found it useful for treating persistent pain from fibromyalgia and diabetic neuropathy.

Saarto T, Wiffen P. Antidepressants for Neuropathic Pain. Cochrane Database of Systematic Reviews. 2007; http://summaries.cochrane.org/CD005454/antidepressants-for-treating-neuropathic-pain

Reference

Title
Antidepressants for Neuropathic Pain
Publication
Cochrane Database of Systematic Reviews
Publication Date
2007
Authors
Saarto T, Wiffen P
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Brain imaging is showing that pain changes the structure and function of brain regions that perceive pain, making it persistent. These brain networks and receptor targets are being identified…  
  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • Researchers have developed several sub-types of ion channels that allow inflammation and growth factors to trigger persistent pain.